Meeting
2017 ASCO Annual Meeting
Metabolic barriers to immunotherapy in renal cell carcinoma.
Authors
Katy Beckermann
Vanderbilt University, Nashville, TN
Katy Beckermann , Peter Siska , Frank Mason , Kimryn Rathmell , Jeffrey C Rathmell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Immunobiology
Citation
J Clin Oncol 35, 2017 (suppl; abstr 11560)
DOI
10.1200/JCO.2017.35.15_suppl.11560
Abstract #
11560
Poster Bd #
260
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Various checkpoint proteins, and tumor infiltrating lymphocytes in common pediatric solid tumors: Possibilities for novel immunotherapy.
First Author: Kazuhiro Mochizuki
Poster
2017 Genitourinary Cancers Symposium
Correlation between inflammatory markers in blood and expression of costimulatory molecules on tumor-infiltrating CD8+ lymphocytes in renal cell carcinoma.
First Author: Haydn T. Kissick
Poster
2024 ASCO Genitourinary Cancers Symposium
Topological heterogeneity of genomic and immunologic effects from combination immunotherapy treatment in the neoadjuvant setting for renal cell carcinoma (RCC).
First Author: Tyler Alban
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu